Your browser doesn't support javascript.
loading
PCSK9: Regulation and Target for Drug Development for Dyslipidemia.
Burke, Amy C; Dron, Jacqueline S; Hegele, Robert A; Huff, Murray W.
Afiliação
  • Burke AC; Department of Biochemistry, Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada N6A 5B7; email: aburke42@uwo.ca , jdron@uwo.ca , hegele@robarts.ca , mhuff@uwo.ca.
  • Dron JS; Department of Biochemistry, Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada N6A 5B7; email: aburke42@uwo.ca , jdron@uwo.ca , hegele@robarts.ca , mhuff@uwo.ca.
  • Hegele RA; Department of Biochemistry, Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada N6A 5B7; email: aburke42@uwo.ca , jdron@uwo.ca , hegele@robarts.ca , mhuff@uwo.ca.
  • Huff MW; Department of Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada N6A 5B7.
Annu Rev Pharmacol Toxicol ; 57: 223-244, 2017 01 06.
Article em En | MEDLINE | ID: mdl-27575716

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Dislipidemias / Descoberta de Drogas / Pró-Proteína Convertase 9 / Inibidores de PCSK9 Limite: Animals / Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Dislipidemias / Descoberta de Drogas / Pró-Proteína Convertase 9 / Inibidores de PCSK9 Limite: Animals / Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Ano de publicação: 2017 Tipo de documento: Article